Macallan Derek C, Borghans José A M, Asquith Becca
Institute for Infection & Immunity, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London SW17 0QT, UK.
Vaccines (Basel). 2017 Feb 4;5(1):5. doi: 10.3390/vaccines5010005.
Long-term T cell-mediated protection depends upon the formation of a pool of memory cells to protect against future pathogen challenge. In this review we argue that looking at T cell memory from a dynamic viewpoint can help in understanding how memory populations are maintained following pathogen exposure or vaccination. For example, a dynamic view resolves the apparent paradox between the relatively short lifespans of individual memory cells and very long-lived immunological memory by focussing on the persistence of clonal populations, rather than individual cells. Clonal survival is achieved by balancing proliferation, death and differentiation rates within and between identifiable phenotypic pools; such pools correspond broadly to sequential stages in the linear differentiation pathway. Each pool has its own characteristic kinetics, but only when considered as a population; single cells exhibit considerable heterogeneity. In humans, we tend to concentrate on circulating cells, but memory T cells in non-lymphoid tissues and bone marrow are increasingly recognised as critical for immune defence; their kinetics, however, remain largely unexplored. Considering vaccination from this viewpoint shifts the focus from the size of the primary response to the survival of the clone and enables identification of critical system pinch-points and opportunities to improve vaccine efficacy.
长期的T细胞介导的保护作用依赖于记忆细胞池的形成,以抵御未来病原体的挑战。在本综述中,我们认为从动态的角度看待T细胞记忆有助于理解病原体暴露或接种疫苗后记忆细胞群体是如何维持的。例如,动态视角通过关注克隆群体而非单个细胞的持久性,解决了单个记忆细胞相对较短寿命与非常长寿的免疫记忆之间的明显矛盾。克隆存活是通过平衡可识别表型池内部和之间的增殖、死亡和分化速率来实现的;这些池大致对应于线性分化途径中的连续阶段。每个池都有其自身的特征动力学,但只有将其视为一个群体时才如此;单个细胞表现出相当大的异质性。在人类中,我们倾向于关注循环细胞,但非淋巴组织和骨髓中的记忆T细胞对免疫防御的重要性越来越受到认可;然而,它们的动力学在很大程度上仍未被探索。从这个角度考虑疫苗接种,将重点从初次反应的大小转移到克隆的存活上,并能够识别关键的系统瓶颈以及提高疫苗效力的机会。